$ARIA ARIAD PHARMACEUTICALS INC Insider Trading Week 12/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARIAD PHARMACEUTICALS INC in week 12/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 6.58 | 23,834 | 156,871 | 316,212 | 340 K to 316.2 K (-7.01 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 8,000 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 6.47 | 4,000 | 25,867 | 93,039 | 97 K to 93 K (-4.12 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 8,000 | 0 | 97,039 | 89 K to 97 K (+8.98 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Option Exercise | M | 0.00 | 4,750 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Sell | S | 6.47 | 2,375 | 15,356 | 262,115 | 264.5 K to 262.1 K (-0.90 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Buy | M | 0.00 | 4,750 | 0 | 264,490 | 259.7 K to 264.5 K (+1.83 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | M | 0.00 | 8,000 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Sell | S | 6.47 | 4,000 | 25,871 | 155,088 | 159.1 K to 155.1 K (-2.51 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Buy | M | 0.00 | 8,000 | 0 | 159,088 | 151.1 K to 159.1 K (+5.29 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Sell | S | 6.46 | 3,575 | 23,102 | 135,667 | 139.2 K to 135.7 K (-2.57 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Buy | M | 0.00 | 6,500 | 0 | 139,242 | 132.7 K to 139.2 K (+4.90 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 0.00 | 10,833 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 6.47 | 5,417 | 35,039 | 340,046 | 345.5 K to 340 K (-1.57 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 0.00 | 10,833 | 0 | 345,463 | 334.6 K to 345.5 K (+3.24 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP | Option Exercise | M | 0.00 | 10,833 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP | Sell | S | 6.47 | 5,417 | 35,037 | 320,367 | 325.8 K to 320.4 K (-1.66 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP | Buy | M | 0.00 | 10,833 | 0 | 325,784 | 315 K to 325.8 K (+3.44 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Sell | S | 6.47 | 3,575 | 23,116 | 147,011 | 150.6 K to 147 K (-2.37 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Buy | M | 0.00 | 6,500 | 0 | 150,586 | 144.1 K to 150.6 K (+4.51 %) |
| Mar 22 2016 | ARIA | ARIAD PHARMACEUTIC ... | Soni Manmeet Singh | EVP, CFO & Treasure ... | Option Exercise | A | 6.47 | 550,000 | 3,558,500 | 550,000 |